Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.7 USD | +0.30% | -6.29% | -40.29% |
May. 15 | HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating | MT |
May. 14 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 |
Financials (USD)
Sales 2024 * | 63.08M | Sales 2025 * | 66.72M | Capitalization | 183M |
---|---|---|---|---|---|
Net income 2024 * | 11M | Net income 2025 * | 16M | EV / Sales 2024 * | 2.89 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 2.74 x |
P/E ratio 2024 * |
16.2
x | P/E ratio 2025 * |
11.4
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.16% |
Latest transcript on Fennec Pharmaceuticals Inc.
1 day | +0.30% | ||
1 week | -6.29% | ||
Current month | -1.18% | ||
1 month | -27.41% | ||
3 months | -29.99% | ||
6 months | -27.49% | ||
Current year | -40.29% |
Managers | Title | Age | Since |
---|---|---|---|
Rostislav Raykov
CEO | Chief Executive Officer | 48 | 09-07-06 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 09-07-06 |
Adrian Haigh
COO | Chief Operating Officer | 64 | 14-04-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chris Rallis
BRD | Director/Board Member | 70 | 11-08-24 |
Khalid Islam
CHM | Chairman | 67 | 14-04-24 |
Robert Andrade
DFI | Director of Finance/CFO | 49 | 09-07-06 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +4.32% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 6.7 | +0.30% | 98,197 |
24-06-04 | 6.68 | -0.74% | 103,997 |
24-06-03 | 6.73 | -0.74% | 126,790 |
24-05-31 | 6.78 | -1.02% | 101,374 |
24-05-30 | 6.85 | -4.20% | 111,143 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.29% | 183M | |
+18.72% | 123B | |
+14.53% | 107B | |
-2.88% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-11.83% | 16.23B | |
+1.46% | 13.43B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- FENC Stock